Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (PROFILE 1001)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Pfizer
Information provided by (Responsible Party):
Pfizer Identifier:
First received: December 29, 2007
Last updated: September 29, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2019
  Estimated Primary Completion Date: November 2019 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):